Tải bản đầy đủ (.pdf) (3 trang)

Andersons pediatric cardiology 1320

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (86.78 KB, 3 trang )

HepaticHemangioma
ClinicalFeatures,Investigations,and
Management
Hepatichemangiomasaretechnicallynotarteriovenousmalformations(AVMs),
butratherneoplasmsrepresentingbenignendothelialtumors.4Hepatic
hemangiomascanbebroadlyclassifiedintotwovarieties:congenitaland
infantile.Bothtypesofhemangiomascanexistinextrahepaticlocations,butthe
cardiovascularramificationsexistonlyincasesofhepatichemangioma;hence
ourdiscussionwillbelimitedtohemangiomaspresentingintheliver.Patients
withhepatichemangiomascommonlyhaveassociatedskinhemangiomas,
frequentlymultiple,andtheirpresencemaybetheinitialpresentingfeatureand
shouldpromptasearchforliverhemangioma.Olderliteratureoftenusedthe
termhemangioendothelioma,butthistermwasimpreciseandcouldrepresent
differententities,includingcongenitalorinfantilehemangiomasandeven
malignantangiosarcomas;hencethetermhemangioendotheliomaiscurrently
discouraged.1,5
Congenitalhemangiomaisabenignneoplasmofendothelialoriginthatbegins
proliferatinginuteroandisfullyformedat,orjustbefore,birthandthenfollows
oneofthreepatternsofnaturalevolutiondependingonthesubtype:rapidly
involuting(until15to24monthsofage),partiallyinvoluting,or
noninvoluting.1,6Affectedinfantsmaypresentwithlivermanifestations
(varicealbleeding,hepatomegaly,splenomegaly),hematologicmanifestations
(anemiaandthrombocytopenia),andhigh-outputCHFduetomassive
arteriovenousshunting.Inaddition,cyanosismayoccurduetoright-to-left
shuntingacrossintracardiaccommunicationssuchasanatrialseptaldefector
patentarterialduct.Becausecongenitalhemangiomashavereachedtheirpeak
sizeatbirth,thesevariousmanifestations(e.g.,CHF)areusuallypresent
immediatelyafterbirthifthetumorsarelargeenoughtocausethesesequelae.
Thediagnosisofcongenitalhepatichemangiomaisusuallymadeusing
noninvasiveimaging.Thestudyofchoiceistwo-dimensionalultrasoundwith
Doppler.Theultrasoundappearancecanbevariable,rangingfromahypoechoic


tohyperechoicmass,andlargerhemangiomascanhaveamorecomplex
appearancethatcanincludecalcifications,thrombosis,andfibrosis.7Ifthe


diagnosisisunclear,alivermagneticresonanceimaging(MRI)studywith
contrastanddynamicacquisitionpatterncanbeperformedandtypicallyreveals
ahypointenselesiononT1-weightedandhyperintenselesiononT2-weighted
images.7Congenitalhemangiomasaremostcommonlysingletumors.The
differentialdiagnosisofasolitarylivermasspresentatbirthorshortlythereafter
includeshepatoblastoma,metastaticneuroblastoma,orhamartoma.7However,
typically,hepatoblastomawouldlacktherimenhancementseeninhemangiomas
andwouldbeassociatedwithelevatedα-fetoproteinlevels.Althoughcongenital
hemangiomacanusuallybediagnosedbasedsolelyonnoninvasiveimaging,a
biopsymaybeoccasionallyrequired;itisthereforeimportanttonotethat
congenitalhemangiomadoesnotexpressglucosetransporter-1orlymphatic
markers.8
Congenitalhemangiomacanfollowoneofthreenaturalpatternsofevolution:
rapidlyinvolutingcongenitalhemangiomawilltypicallyinvolutewithinthefirst
24monthsoflife,butmostregressby3monthsofage,9whereasnoninvoluting
congenitalhemangiomawillgenerallynotpersist,andathirdintermediateform
isconsideredtobepartiallyinvoluting.6,10,11
Infantilehemangiomasarethemostcommonofallchildhoodtumorsand
representanentitythatisdistinctfromcongenitalhemangiomas.Infantile
hemangiomascontinuetoproliferateafterbirthandmayreachpeaksizeby6to
12monthsofage,whetherthesearecutaneous,hepatic,orinotherlocations.5
Althoughinfantilehemangiomascanpresentwithverysimilarhematologic,
hepatic,andcardiovascularmanifestationsascongenitalhemangiomas,an
importantdistinctionisthatininfantilehemangiomasthesefeatureswillnotbe
presentatbirthbutmaydevelopduringinfancyifthetumormassreachesa
sufficientsize.Anotherdistinguishingfeatureisthatinfantilehemangiomasmay

expresshighlevelsoftype3iodothyroninedeiodinase,leadingtoinactivationof
circulatingthyroidhormoneandclinicalhypothyroidism.12Itisimportantto
notethatthisformofinfantilehypothyroidismwouldnotbedetectedby
newbornscreeningbecauseitisexpectedtodeveloponlyafterseveralmonthsof
tumorgrowth.
Thediagnosisofinfantileliverhemangiomasisusuallyalsomadebasedon
noninvasiveimaging,usuallyultrasoundwithDoppler,althoughliverMRIalso
playsanimportantrole.Unlikecongenitalhepatichemangiomas,whicharemost
commonlysolitarylesions,infantilehemangiomasaremoreoftenmultifocalor
diffuse.13Althoughbiopsyisnottypicallyrequiredtomakethediagnosis,


infantilehemangiomascharacteristicallyexpressglucosetransporter-1,an
importantandveryspecificdistinguishingfeature.8Theclinicalcourseof
infantilehemangiomaisoneofuniversalgrowthofthetumorupto12monthsof
age,followedbygradualregressionuntilapproximately9yearsorage.
Infantileliverhemangiomasandcongenitalliverhemangiomasofinvoluting
typesmaybeobservedwithouttreatmentinasymptomaticindividuals.Although
asymptomaticinfantsmaybeobserved,theprognosisispoorinuntreatedinfants
presentingwithheartfailure,withanestimated80%to90%mortality.For
patientswithsignificantclinicalmanifestations,suchasCHFand
hypothyroidism,propranolol1to3mg/kgperdayhasbecomethemainstayof
therapyandhasbeenreportedtobeeffectiveforhepaticinfantile
hemangiomas.14,15Thereisnoevidencethatanypharmacotherapyaccelerates
theregressionofrapidlyinvolutingcongenitalhemangiomalesions.14Inthe
past,corticosteroidsandinterferon-αwererecommended,buttheirusehasbeen
supplantedbypropranololduetoitsgreaterefficacyandlowerside-effect
profile.Transcatheterembolization(TCE)maybeoccasionallyrequiredto
controlseveresymptomsuntilpropranololortimeresultinsufficientregression.
Anatomically,theseliverneoplasmsmaypossesshepaticarterialsupply,aswell

asextrahepaticarterialsupplyviathesuperiormesenteric,phrenic,renal,or
intercostalarteries.Inaddition,portalvenoussupplymayalsoexistandhasbeen
correlatedwithincreasedlikelihoodofCHF.7,16Aclearunderstandingofthe
vascularanatomyisnecessarytocarryoutaneffectiveembolization.Surgical
hepaticarteryligationisnowrarelyused.Similarly,surgicalresectionisonly
rarelyrequired,andlivertransplantationisreservedforpatientswithabdominal
compartmentsyndromeforwhomtheremaynotbetimetoallowfor
spontaneousorpharmacotherapy-assistedregression.14



×